Back4D Molecular Therapeutics Overview

4D Molecular Therapeutics Operating Income

Operating Income for FDMT.

Quarterly Operating Income

$-73620000.00
↑ 37.3% YoY

As of Mar 31, 2026

Annual Operating Income (TTM)

$-179546000.00
↓ 11.7% YoY

Trailing 12 months ending Mar 31, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin